Inovio Pharmaceuticals Inc. | Key People and Executives
Avtar S. Dhillon
Non-Executive Chairman
J. Joseph Kim
President, Chief Executive Officer & Director
David B. Weiner
Director & Executive Vice President
Wendy L. Yarno
Independent Director
Mort C. Collins
Independent Director
Simon X. Benito
Independent Director
Adel A. F. Mahmoud
Independent Director
Angel Cabrera
Independent Director
Avtar S. Dhillon
Non-Executive Chairman
J. Joseph Kim
President, Chief Executive Officer & Director
Niranjan Y. Sardesai
Chief Operating Officer
Peter D. Kies
Chief Financial Officer
Mark L. Bagarazzi
Chief Medical Officer
Laurent M. Humeau
Senior Vice President-Research & Development
Shawn D. Bridy
Vice President-Business Development
Scott M. White
Vice President-Clinical Development
Jessica C. Lee
Vice President-Clinical Operations & Compliance
Jeffrey C. Richardson
Vice President-Strategic Relations
David B. Weiner
Director & Executive Vice President
Jeffrey Skolnik
Vice President-Clinical Development
Prakash Bhuyan
Vice President-Clinical Development
Maggie Campbell
Director-Finance
Ben Matone
Head-Investor Relations
Ami Shah Brown
Vice President-Regulatory Affairs
Wendy L. Yarno
Independent Director
Morton C. Collins
Independent Director
Simon X. Benito
Independent Director
Adel A. F. Mahmoud
Independent Director
Angel Cabrera
Independent Director
| Address |
660 West Germantown Pike
Plymouth Meeting Pennsylvania 19462
United States
|
|
Employees
|
- |
| Website |
http://www.inovio.com |
| Updated |
07/08/2019 |
| Inovio Pharmaceuticals, Inc. engages in the development of active DNA immunotherapies for cancer and infectious diseases. Its portfolio of immune therapies includes SynCon immunotherapies and electroporation delivery systems. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA. |
